Status:
COMPLETED
Automated Oxygen Administration -Rethinking Interventions Alleviating Dyspnea in Patients With COPD
Lead Sponsor:
Copenhagen University Hospital, Hvidovre
Conditions:
COPD
Hypoxia
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is associated with high morbidity and mortality. The Danish Lung Association estimates that 320,000 Danes live with COPD, of which approximately 50,000 wit...
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is a high prevalence disease and is associated with high morbidity and mortality worldwide. In 2017, there were 23.979 COPD related admissions in Denmark, ...
Eligibility Criteria
Inclusion
- COPD veryfied by Forced Expiratory Volume in 1 sec (Fev1) divided by forced Vital Capacity (FVC)\< 0,70
- Admission due to exercabation in COPD
- COPD exacerbation and pneumonia can be included
- Expeted duration of admission \>48 hours
- Need for oxygen supplementation (SpO2\<= 88% in room air) Cognitive able to participate in the study
- Willing to participate and give informed consent
Exclusion
- Need or anticipated need for mechanical ventilation ( Intermittent continuous Positive Airway Pressure (CPAP) is allowed)
- Major comorbidities causing hypoxemia (cancer, heart disease, pulmonary embolia)
- Asthma or other respiratory conditions requiring higher SpO2 than normal for COPD Pregnancy
- Cognitive barrierers for participation
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
157 Patients enrolled
Trial Details
Trial ID
NCT04370990
Start Date
September 1 2019
End Date
May 1 2022
Last Update
October 26 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg University Hospital
Copenhagen, Denmark, 2400
2
Hvidovre University Hospital
Copenhagen, Denmark, 2650
3
Herlev University Hospital
Copenhagen, Denmark, 2730
4
Gentofte University Hospital
Copenhagen, Denmark, 2900